Singapore Medical Group (SMG)

M&A

Singapore Medical Group acquires paediatric clinic for $7.9 mil

SINGAPORE (Oct 19): Singapore Medical Group is acquiring Babies and Children Specialist Clinic at Mount Alvernia Medical Centre for $7.9 million.

Broker's Calls

Singapore Medical Group kept at ‘buy’ by Maybank on acquisitions, better growth

SINGAPORE (Aug 16): Maybank Kim Eng is reiterating its “buy” call on Singapore Medical Group (SMG) with a target price of 78 cents.

Results

Singapore Medical Group’s 1H earnings up sixfold to $4 mil on higher revenue

SINGAPORE (Aug 14): Singapore Medical Group (SMG) has announced earnings of $4 million for the half-year ended June, a more-than sixfold improvement compared to its $0.63 million in earnings for 1H16.

Broker's Calls

Singapore Medical Group kept at ‘buy’ on experienced and well connected leadership

SINGAPORE (June 5): Maybank Kim Eng is maintaining its “buy” call on Singapore Medical Group (SMG) with a target price of 78 cents.

Broker's Calls

Singapore Medical Group growing stronger with string of acquisitions

SINGAPORE (April 24): RHB Research is keeping its “buy” recommendation on Singapore Medical Group (SMG) with a higher target price of 79 cents, from 65 cents previously.

Broker's Calls

Singapore Medical Group kept at ‘buy’ following price correction

SINGAPORE (April 5): Maybank Kim Eng Research says Singapore Medical Group’s share price correction of close to 8% from its 52-week high presents a “good buying opportunity”.

In print this week

Should Asian investors buy into the story of rising healthcare demand?

SINGAPORE (March 31): At least one observer has held up Singapore’s healthcare system as a model for the developed world. But the system is not without its own issues.

Broker's Calls

Reinvigorated Singapore Medical Group ready to soar

SINGAPORE (Mar 1): RHB is keeping Singapore Medical Group (SMG) on “buy” with a higher target price of 65 cents, from 59 cents previously, on the back of its expanding war chest.

Broker's Calls

Singapore Medical Group could re-rate following Korean tie-up

SINGAPORE (Feb 20): Singapore Medical Group could see a re-rating as its market recognition and track record grows following its tie-up with Korean healthcare group CHA Medical Group, according to Maybank Kim Eng.

Broker's Calls

Singapore Medical Group set for overseas expansion with new strategic stake partner

SINGAPORE (Feb 17): Singapore Medical Group says a leading Korean healthcare group is taking a 8.8% strategic stake in the provider of premium specialist healthcare services.
×